207 related articles for article (PubMed ID: 16734421)
1. Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu.
Parmeggiani A; Krab IM; Okamura S; Nielsen RC; Nyborg J; Nissen P
Biochemistry; 2006 Jun; 45(22):6846-57. PubMed ID: 16734421
[TBL] [Abstract][Full Text] [Related]
2. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
3. Elongation factor Tu-targeted antibiotics: four different structures, two mechanisms of action.
Parmeggiani A; Nissen P
FEBS Lett; 2006 Aug; 580(19):4576-81. PubMed ID: 16876786
[TBL] [Abstract][Full Text] [Related]
4. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Möhrle VG; Tieleman LN; Kraal B
Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
[TBL] [Abstract][Full Text] [Related]
5. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
[TBL] [Abstract][Full Text] [Related]
6. Probing the reactivity of the GTP- and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A.
Anborgh PH; Parmeggiani A
J Biol Chem; 1993 Nov; 268(33):24622-8. PubMed ID: 8227020
[TBL] [Abstract][Full Text] [Related]
7. New antibiotic that acts specifically on the GTP-bound form of elongation factor Tu.
Anborgh PH; Parmeggiani A
EMBO J; 1991 Apr; 10(4):779-84. PubMed ID: 2009857
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of intact elongation factor EF-Tu from Escherichia coli in GDP conformation at 2.05 A resolution.
Song H; Parsons MR; Rowsell S; Leonard G; Phillips SE
J Mol Biol; 1999 Jan; 285(3):1245-56. PubMed ID: 9918724
[TBL] [Abstract][Full Text] [Related]
9. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics MDL 62,879 and kirromycin bind to distinct and independent sites of elongation factor Tu (EF-Tu).
Landini P; Soffientini A; Monti F; Lociuro S; Marzorati E; Islam K
Biochemistry; 1996 Dec; 35(48):15288-94. PubMed ID: 8952479
[TBL] [Abstract][Full Text] [Related]
11. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
[TBL] [Abstract][Full Text] [Related]
12. Structure and importance of the dimerization domain in elongation factor Ts from Thermus thermophilus.
Jiang Y; Nock S; Nesper M; Sprinzl M; Sigler PB
Biochemistry; 1996 Aug; 35(32):10269-78. PubMed ID: 8756682
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis of glutamine 290 in Escherichia coli and mitochondrial elongation factor Tu affects interactions with mitochondrial aminoacyl-tRNAs and GTPase activity.
Hunter SE; Spremulli LL
Biochemistry; 2004 Jun; 43(22):6917-27. PubMed ID: 15170329
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of active elongation factor Tu reveals major domain rearrangements.
Berchtold H; Reshetnikova L; Reiser CO; Schirmer NK; Sprinzl M; Hilgenfeld R
Nature; 1993 Sep; 365(6442):126-32. PubMed ID: 8371755
[TBL] [Abstract][Full Text] [Related]
15. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
Navratil T; Spremulli LL
Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
[TBL] [Abstract][Full Text] [Related]
16. Possible evolution of factors involved in protein biosynthesis.
Nyborg J
Acta Biochim Pol; 1998; 45(4):883-94. PubMed ID: 10397336
[TBL] [Abstract][Full Text] [Related]
17. Pulvomycin-resistant mutants of E.coli elongation factor Tu.
Zeef LA; Bosch L; Anborgh PH; Cetin R; Parmeggiani A; Hilgenfeld R
EMBO J; 1994 Nov; 13(21):5113-20. PubMed ID: 7957075
[TBL] [Abstract][Full Text] [Related]
18. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.
Heffron SE; Jurnak F
Biochemistry; 2000 Jan; 39(1):37-45. PubMed ID: 10625477
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of elongation factor Tu (EF-Tu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62879.
Landini P; Bandera M; Soffientini A; Goldstein BP
J Gen Microbiol; 1993 Apr; 139(4):769-74. PubMed ID: 8515234
[TBL] [Abstract][Full Text] [Related]
20. The conformational properties of elongation factor G and the mechanism of translocation.
Czworkowski J; Moore PB
Biochemistry; 1997 Aug; 36(33):10327-34. PubMed ID: 9254632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
